Abstract:Background: The development of drug resistance and the persistence of leukemia stem cells are major obstacles for the use of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML). The induction of autophagic death in tumor cells represents a new route for leukemia treatment. Our previous study showed that infection of CML cells with oncolytic viruses carrying the autophagy gene Beclin1 downregulated BCR/ABL protein expression and significantly increased the killing effect of the oncolytic viruses on CML cells via autophagy activation. However, the specific molecular mechanisms underlying the regulation of BCR/ABL and Beclin1-dependent CML cell killing remain unclear. Methods: A physical interaction between BCR/ABL and Beclin1 was characterized via GST-pulldown, co-IP and dual-luciferase reporter assays. Cell proliferation was examined via CCK-8 and clone formation assays. The expression levels of the related proteins were measured via Western blotting. Autophagosomes were observed under transmission electron microscopy. Lentiviral vectors carrying Atg7/UVRAG shRNA or the Beclin1 gene were used to modulate the expression levels of the indicated genes. Immunofluorescence were performed to examine colocalization of BCR/ABL and p62/SQSTM1. CD34(+)CD38(-) cells were isolated from bone marrow samples from CML patients via fluorescence-activated cell sorting. Results: In this study, we observed that Beclin1 directly interacts with BCR/ABL. Beclin1 inhibited the activity of the BCR/ABL promoter to downregulate the level of BCR/ABL protein and to promote the downstream colocalization of p62/SQSTM1 and BCR/ABL to autolysosomes for degradation via activation of the autophagy signaling pathway. In CML cell lines, primary cells and CD34(+)CD38(-) leukemia stem cells, Beclin1 overexpression significantly inhibited cell growth and proliferation and induced autophagy. Conclusion: Taken together, our results suggest that autophagy induction via Beclin1 overexpression might offer new approaches for treating TKI-resistant CML and for promoting the clearance of leukemia stem cells, both of which have important clinical implications.

Molecular mechanisms underlying the BIRC6-mediated regulation of apoptosis and autophagy

Structural basis for BIRC6 to balance apoptosis and autophagy

Structural basis for regulation of apoptosis and autophagy by the BIRC6/SMAC complex

Acetyl-Coenzyme A acyltransferase 2 attenuates the apoptotic effects of BNIP3 in two human cell lines.

SIP/CacyBP promotes autophagy by regulating levels of BRUCE/Apollon, which stimulates LC3-I degradation

BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells

Negative Regulation of Autophagy by UBA6-BIRC6–Mediated Ubiquitination of LC3

A Regulatory Circuit Comprising the CBP and SIRT7 Regulates FAM134B-mediated ER-phagy.

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy.

Inhibition of BAK-mediated apoptosis by the BH3-only protein BNIP5

Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis

Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy

The Chaperone BAG6 Regulates Cellular Homeostasis between Autophagy and Apoptosis by Holding LC3B

IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation

Parkin-mediated Ubiquitination Inhibits BAK Apoptotic Activity by Blocking Its Canonical Hydrophobic Groove

Bcl-2 family members: Dual regulators of apoptosis and autophagy

BIRC6 Modulates the Protein Stability of Axin to Regulate the Growth, Stemness, and Resistance of Renal Cancer Cells via the β-Catenin Pathway

Chaperone-mediated autophagy prevents apoptosis by degrading BBC3/PUMA

Inhibition of BAK Apoptotic Activity by Parkin-mediated Ubiquitination

Beclin 1 Bridges Autophagy, Apoptosis and Differentiation

The Selective Activation of P53 Target Genes Regulated by SMYD2 in BIX-01294 Induced Autophagy-Related Cell Death.